Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |